Targeting human glioblastoma cells: Comparison of nine viruses with oncolytic potential

Journal of Virology

Volumn 79, Issue 10, 2005, Pages 6005-6022

  Wollmann, Guido ^a   Tattersall, Peter ^a   Van Den Pol, Anthony N ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GREEN FLUORESCENT PROTEIN; ONCOLYTIC VIRUS;

ADENO ASSOCIATED VIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL STRAIN; CONTROLLED STUDY; FIBROBLAST CULTURE; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; MOUSE; NONHUMAN; PARVOVIRUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN ISOLATION; PSEUDORABIES HERPETOVIRUS; SIMIAN VIRUS 40; SINDBIS VIRUS; STRAIN DIFFERENCE; TARGET CELL; VESICULAR STOMATITIS VIRUS; VIRUS REPLICATION; VIRUS STRAIN;

ANIMALS; CELL LINE, TUMOR; COCULTURE TECHNIQUES; CYTOPATHOGENIC EFFECT, VIRAL; DNA VIRUSES; FEMALE; GLIOBLASTOMA; HUMANS; MICE; MICE, SCID; MINUTE VIRUS OF MICE; RNA VIRUSES; SINDBIS VIRUS; TRANSPLANTATION, HETEROLOGOUS; VESICULAR STOMATITIS-INDIANA VIRUS; VIRUS REPLICATION;

ADENO-ASSOCIATED VIRUS; HUMAN HERPESVIRUS 5; MICE MINUTE VIRUS; SIMIAE; SIMIAN VIRUS; SIMIAN VIRUS 40; SINDBIS VIRUS; SUID HERPESVIRUS 1;

EID: 18144413065     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.79.10.6005-6022.2005     Document Type: Article

References (67)

1. Ali-Osman, F. 1999. Brain tumors, p. 167-184. In J. R. W. Masters and B. Palson (ed.), Human cell culture, vol. 2. Kluwer Academic Publishers, New York, N.Y.
2. American Cancer Society Surveillance Research. 2002. Cancer facts and figures 2002. American Cancer Society, Inc., Atlanta, Ga.
3. Anderson, C. W., and M. J. Allalunis-Turner. 2000. Human TP53 from the malignant glioma-derived cell lines M059J and M059K has a cancer-associated mutation in exon 8. Radiat. Res. 154:473-476.
4. Anderson, C. W., J. J. Dunn, P. I. Freimuth, A. M. Galloway, and M. J. Allalunis-Turner. 2001. Frameshift mutation in PRKDC, the gene for DNA-PKcs, in the DNA repair-defective, human, glioma-derived cell line M059J. Radiat. Res. 156:2-9.
5. Balachandran, S., and G. N. Barber. 2000. Vesicular stomatitis virus (VSV) therapy of tumors. IUBMB Life 50:135-138.
6. Balachandran, S., M. Porosnicu, and G. N. Barber. 2001. Oncolytic activity of vesicular stomatitis virus is effective against tumors exhibiting aberrant p53, Ras, or myc function and involves the induction of apoptosis. J. Virol. 75:3474-3479.
7. Ball-Goodrich, L. J., and P. Tattersall. 1992. Two amino acid substitutions within the capsid are coordinately required for acquisition of fibrotropism by the lymphotropic strain of minute virus of mice. J. Virol. 66:3415-3423.
8. Bantel-Schaal, U. 1990. Adeno-associated parvoviruses inhibit growth of cells derived from malignant human tumors. Int. J. Cancer 45:190-194.
9. Boldogkoi, Z., A. Bratincsak, and I. Fodor. 2002. Evaluation of pseudorabies virus as a gene transfer vector and an oncolytic agent for human tumor cells. Anticancer Res. 22:2153-2159.
10. Card, J. P., and L. W. Enquist. 1995. Neurovirulence of pseudorabies virus. Crit. Rev. Neurobiol. 9:137-162.
11. Chiocca, E. A., M. Aghi, and G. Fulci. 2003. Viral therapy for glioblastoma. Cancer J. 9:167-179.
12. Clark, K. R., X. Liu, J. P. McGrath, and P. R. Johnson. 1999. Highly purified recombinant adeno-associated virus vectors are biologically active and free of detectable helper and wild-type viruses. Hum. Gene Ther. 10:1031-1039.
13. Cornelis, J. J., N. Salome, C. Dinsart, and J. Rommelaere. 2004. Vectors based on autonomous parvoviruses: novel tools to treat cancer? J. Gene Med. 6(Suppl. 1):S193-S202.
14. Dalton, K. P., and J. K. Rose. 2001. Vesicular stomatitis virus glycoprotein containing the entire green fluorescent protein on its cytoplasmic domain is incorporated efficiently into virus particles. Virology 279:414-421.
15. Drake, J. W., and J. J. Holland. 1999. Mutation rates among RNA viruses. Proc. Natl. Acad. Sci. USA 96:13910-13913.
16. Dupont, F., B. Avalosse, A. Karim, N. Mine, M. Bosseler, A. Maron, A. V. Van den Broeke, G. E. Ghanem, A. Burny, and M. Zeicher. 2000. Tumor-selective gene transduction and cell killing with n oncotropic autonomous parvovirus-based vector. Gene Ther. 7:790-796.
17. Gardiner, E. M., and P. Tattersall. 1988. Evidence that developmentally regulated control of gene expression by a parvoviral allotropic determinant is particle mediated. J. Virol. 62:1713-1722.
18. Germano, I. M., J. Fable, S. H. Gultekin, and A. Silvers. 2003. Adenovirus/herpes simplex-thymidine kinase/ganciclovir complex: preliminary results of a phase I trial in patients with recurrent malignant gliomas. J. Neurooncol. 65:279-289.
19. Griffin, D. E. 2001. Alphaviruses, p. 917-962. In D. M. Knipe and P. M. Howley (ed.), Fields virology, 4th ed. Lippincott-Raven Publishers, Philadelphia, Pa.
20. Griffin, D. E., and J. M. Hardwick. 1997, Regulators of apoptosis on the road to persistent alphavirus infection. Annu. Rev. Microbiol. 51:565-592.
21. Gromier M., S. Lachmann, M. R. Rosenfeld, P. H. Gutin, and E. Wimmer. 2000. Intergeneric poliovirus recombinants for the treatment of malignant glioma. Proc. Natl. Acad. Sci. USA 97:6803-6808.
22. Hardwick, J. M., and B. Levine. 2000. Sindbis virus vector system for functional analysis of apoptosis regulators. Methods Enzymol. 322:492-508.
23. Herrero, Y. C. M., J. J. Cornelis, C. Herold-Mende, J. Rommelaere, J. R. Schlehofer, and K. Geletneky. 2004. Parvovirus H-1 infection of human glioma cells leads to complete viral replication and efficient cell killing. Int. J. Cancer 109:76-84.
24. Ishii, N., D. Maier, A. Merlo, M. Tada, Y. Sawamura, A. C. Diserens, and E. G. Van Meir. 1999. Frequent co-alterations of TP53, p16/CDKN2A, p14ARF, PTEN tumor suppressor genes in human glioma cell lines. Brain Pathol. 9:469-479.
25. Jan, J. T., S. Chatterjee, and D. E. Griffin. 2000. Sindbis virus entry into cells triggers apoptosis by activating sphingomyelinase, leading to the release of ceramide. J. Virol. 74:6425-6432.
26. Jarvis, M. A., C. E. Wang, H. L. Meyers, P. P. Smith, C. L. Corless, G. J. Henderson, J. Vieira, W. J. Britt, and J. A. Nelson. 1999. Human cytomegalovirus infection of caco-2 cells occurs at the basolateral membrane and is differentiation state dependent. J. Virol. 73:4552-4560.
27. Jasani, B., A. Cristaudo, S. A. Emri, A. F. Gazdar, A. Gibbs, B. Krynska, C. Miller, L. Mutti, C. Radu, M. Tognon, and A. Procopio. 2001. Association of SV40 with human tumours. Semin. Cancer Biol. 11:49-61.
28. Lawson, N. D., E. A. Stillman, M. A. Whitt, and J. K. Rose. 1995. Recombinant vesicular stomatitis viruses from DNA. Proc. Natl. Acad. Sci. USA 92:4477-4481.
29. Legrand, C., J. Rommelaere, and P. Caillet-Fauquet. 1993. MVM(p) NS-2 protein expression is required with NS-1 for maximal cytotoxicity in human transformed cells. Virology 195:149-155.
30. Levin, V. A., S. A. Leibel, and P. H. Gutin. 1997. Neoplasms of the central nervous system, p. 2022-2082. In V. T. DeVitra, Jr., S. Hellman, and S. A. Rosenberg (ed.), Cancer principles and practice of oncology, 5th ed. Lippincott-Raven, Philadelphia, Pa.
31. Lewis, J., S. L. Wesselingh, D. E. Griffin, and J. M. Hardwick. 1996. Alpha-virus-induced apoptosis in mouse brains correlates with neurovirulence. J. Virol. 70:1828-1835.
32. Lokensgard, J. R., M. C. Cheeran, G. Gekker, S. Hu, C. C. Chao, and P. K. Peterson. 1999. Human cytomegalovirus replication and modulation of apoptosis in astrocytes. J. Hum. Virol. 2:91-101.
33. Ma, H. I., S. Z. Lin, Y. H. Chiang, J. Li, S. L. Chen, Y. P. Tsao, and X. Xiao. 2002. Intratumoral gene therapy of malignant brain tumor in a rat model with angiostatin delivered by adeno-associated viral (AAV) vector. Gene Ther. 9:2-11.
34. Maxwell, I. H., K. L. Terrell, and F. Maxwell. 2002. Autonomous parvovirus vectors. Methods 28:168-181.
35. Mizuno, M., J. Yoshida, P. Colosi, and G. Kurtzman. 1998. Adeno-associated virus vector containing the herpes simplex virus thymidine kinase gene causes complete regression of intracerebrally implanted human gliomas in mice, in conjunction with ganciclovir administration. Jpn J. Cancer Res. 89:76-80.
36. Mocarski, E. S., and C. T. Courcelle. 2001. Cytomegaloviruses and their replication, p. 2629-2673. In D. M. Knipe and P. M. Howley (ed.), Fields virology, 4th ed. Lippincott-Raven Publishers, Philadelphia, Pa.
37. Mohapatra, G., D. H. Kim, and B. G. Feuerstein. 1995. Detection of multiple gains and losses of genetic material in ten glioma cell lines by comparative genomic hybridization. Genes Chromosomes Cancer 13:86-93.
38. Naeger, L. K., E. C. Goodwin, E. S. Hwang, R. A. DeFilippis, H. Zhang, and D. DiMaio. 1999. Bovine papillomavirus E2 protein activates a complex growth-inhibitory program in p53-negative HT-3 cervical carcinoma cells that includes repression of cyclin A and cdc25A phosphatase genes and accumulation of hypophosphorylated retinoblastoma protein. Cell Growth Differ. 10:413-422.
39. Nister, M., T. A. Libermann, C. Betsholtz, M. Pettersson, L. Claesson-Welsh, C. H. Heldin, J. Schlessinger, and B. Westermark. 1988. Expression of messenger RNAs for platelet-derived growth factor and transforming growth factor-alpha and their receptors in human malignant glioma cell lines. Cancer Res. 48:3910-3918.
40. Obuchi, M., M. Fernandez, and G. N. Barber. 2003. Development of recombinant vesicular stomatitis viruses that exploit defects in host defense to augment specific oncolytic activity. J. Virol. 77:8843-8856.
41. cip1. J. Virol. 75:11071-11078.
42. Phuong, L. K., C. Allen, K. W. Peng, C. Giannini, S. Greiner, C. J. TenEyck, P. K. Mishra, S. I. Macura, S. J. Russell, and E. C. Galanis. 2003. Use of a vaccine strain of measles virus genetically engineered to produce carcinoembryonic antigen as a novel therapeutic agent against glioblastoma multiforme. Cancer Res. 63:2462-2469.
43. Prieto, J., J. Solera, and E. Tabares. 2002. Development of new expression vector based on pseudorabies virus amplicons: application to human insulin expression. Virus Res. 89:123-129.
44. Puumalainen, A. M., M. Vapalahti, R. S. Agrawal, M. Kossila, J. Laukkanen, P. Lehtolainen, H. Viita, L. Paljarvi, R. Vanninen, and S. Yla-Herttuala. 1998. Beta-galactosidase gene transfer to human malignant glioma in vivo using replication-deficient retroviruses and adenoviruses. Hum. Gene Ther. 9:1769-1774.
45. Rainov, N. G., and H. Ren. 2003. Clinical trials with retrovirus mediated gene therapy-what have we learned? J. Neurooncol. 65:227-236.
46. Rainov, N. G., and H. Ren. 2003. Gene therapy for human malignant brain tumors. Cancer J. 9:180-188.
47. Rose, J. K., and M. A. Whitt. 2001. Rhabdoviridae: the viruses and their replication, p. 1221-1244. In D. M. Knipe and P. M. Howley (ed.), Fields virology, 4th ed. Lippincott-Raven Publishers, Philadelphia, Pa.
48. Rubio, M. P., S. Guerra, and J. M. Almendral. 2001. Genome replication and postencapsidation functions mapping to the nonstructural gene restrict the host range of a murine parvovirus in human cells. J. Virol. 75:11573-11582.
49. Russell, S. J., A. Brandenburger, C. L. Flemming, M. K. Collins, and J. Rommelaere. 1992. Transformation-dependent expression of interleukin genes delivered by a recombinant parvovirus. J. Virol. 66:2821-2828.
50. Schlehofer, J. R. 1994. The tumor suppressive properties of adeno-associated viruses. Mutat. Res. 305:303-313.
51. Shaughnessy, E., D. Lu, S. Chatterjee, and K. K. Wong. 1996. Parvoviral vectors for the gene therapy of cancer. Semin. Oncol. 23:159-171.
52. Smith, B. N., B. W. Banfield, C. A. Smeraski, C. L. Wilcox, F. E. Dudek, L. W. Enquist, and G. E. Pickard. 2000. Pseudorabies virus expressing enhanced green fluorescent protein: a tool for in vitro electrophysiological analysis of transsynaptically labeled neurons in identified central nervous system circuits. Proc. Natl. Acad. Sci. USA 97:9264-9269.
53. Stojdl, D. F., B. Lichty, S. Knowles, R. Marius, H. Atkins, N. Sonenberg, and J. C. Bell. 2000. Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus. Nat. Med. 6:821-525.
54. Stojdl, D. F., B. D. Lichty, B. R. tenOever, J. M. Paterson, A. T. Power, S. Knowles, R. Marius, J. Reynard, L. Poliquin, H. Atkins, E. G. Brown, R. K. Durbin, J. E. Durbin, J. Hiscott, and J. C. Bell. 2003. VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents. Cancer Cell 4:263-275.
55. Tattersall, P., and J. Bratton. 1983. Reciprocal productive and restrictive virus-cell interactions of immunosuppressive and prototype strains of minute virus of mice. J. Virol. 46:944-955.
56. Timiryasova, T. M., J. Li, B. Chen, D. Chong, W. H. Langridge, D. S. Gridley, and I. Fodor. 1999. Antitumor effect of vaccinia virus in glioma model. Oncol. Res. 11:133-144.
57. Tseng, J. C., B. Levin, A. Hurtado, H. Yee, I. Perez de Castro, M. Jimenez, P. Shamamian, R. Jin, R. P. Novick, A. Pellicer, and D. Meruelo. 2004. Systemic tumor targeting and killing by Sindbis viral vectors. Nat. Biotechnol. 22:70-77.
58. van den Pol, A. N., K. P. Dalton, and J. K. Rose. 2002. Relative neurotropism of a recombinant rhabdovirus expressing a green fluorescent envelope glycoprotein. J. Virol. 76:1309-1327.
59. van den Pol, A. N., E. Mocarski, N. Saederup, J. Vieira, and T. J. Meier. 1999. Cytomegalovirus cell tropism, replication, and gene transfer in brain. J. Neurosci. 19:10948-10965.
60. Van den Pol, A. N., J. Vieira, D. D. Spencer, and J. G. Santarelli. 2000. Mouse cytomegalovirus in developing brain tissue: analysis of 11 species with GFP-expressing recombinant virus. J. Comp. Neurol. 427:559-580.
61. Vecil, G. G., and F. F. Lang. 2003. Clinical trials of adenoviruses in brain tumors: a review of Ad-p53 and oncolytic adenoviruses. J. Neurooncol. 65:237-246.
62. Vilchez, R. A., and J. S. Butel. 2003. SV40 in human brain cancers and non-Hodgkin's lymphoma. Oncogene 22:5164-5172.
63. Wang, K. S., R. J. Kuhn, E. G. Strauss, S. Ou, and J. H. Strauss. 1992. High-affinity laminin receptor is a receptor for Sindbis virus in mammalian cells. J. Virol. 66:4992-5001.
64. Wrensch, M., Y. Minn, T. Chew, M. Bondy, and M. S. Berger. 2002. Epidemiology of primary brain tumors: current concepts and review of the literature. Neuro-oncology 4:278-299.
65. Yoshida, J., M. Mizuno, N. Nakahara, and P. Colosi. 2002. Antitumor effect of an adeno-associated virus vector containing the human interferon-beta gene on experimental intracranial human glioma. Jpn. J. Cancer Res. 93:223-228.
66. Zeicher, M., P. Spegelaere, M. Horth, D. Gancberg, A. Karim, and F. Dupont. 2003. Oncoselective parvoviral vector-mediated gene therapy of cancer. Oncol. Res. 13:437-444.
67. Zrachia, A., M. Dobroslav, M. Blass, G. Kazimirsky, I. Kronfeld, P. M. Blumberg, D. Kobiler, S. Lustig, and C. Brodie. 2002. Infection of glioma cells with Sindbis virus induces selective activation and tyrosine phosphorylation of protein kinase C delta. Implications for Sindbis virus-induced apoptosis. J. Biol. Chem. 277:23693-23701.